JAANCH - PCOD ADVANCED

Price: Rs. 5999 Rs. 4750

Thyrocare Jaanch PCOD Advanced For Indian women with complex or severe PCOD requiring deeper investigation, Jaanch PCOD Advanced examines all four biological axes — reproductive, metabolic, thyroid and ovarian reserve — in one comprehensive sample. NABL-accredited lab, free pan-India home collection, reports in 24 hours.

• 

  17 Crores+ Samples Processed

• 

  World Class Technology Labs

• 

  25+ Years of Trust & Experience

• 

  Free Home Collection

Price: ₹ 5,999.00 ₹ 4,750.00

Sample Type: BLOOD

10-12 hrs fasting is required (Only water is allowed)

List of Profiles Included:

Booking Procedure:

1. Technician from Thyrocare will be assigned for a free home sample collection after booking confirmation.
2. Sample will be collected by our technician at your address at given slot.
3. You will get a payment link in 2 hours. You can make the payment online or pay cash to the technician.
4. Soft copy reports will be sent to your email address within 24 to 48 hours.

Frequently Asked Questions (FAQ's):

1. What is the Thyrocare Jaanch PCOD Advanced package and who is it designed for? The Jaanch PCOD Advanced is the most comprehensive PCOD evaluation panel in the Jaanch series, designed for Indian women with complex or severe PCOD, women planning pregnancy after 30, those preparing for IVF or fertility treatment, and women whose previous Basic or Mini reports flagged multiple abnormalities. It examines four biological axes simultaneously — reproductive hormones, ovarian reserve, insulin resistance and thyroid function. The package is processed at a NABL-accredited partner lab and bookable with free pan-India home collection on bookmytest.co.in.

2. How is Thyrocare Jaanch PCOD Advanced different from PCOD Mini, Basic and the full PCOD Profile? The Jaanch ladder works as a depth scale. Mini covers 5–6 essential hormones for first-line screening. Basic adds fasting insulin and DHEA-S, ideal for working women and pre-pregnancy planning. Advanced takes it further by including AMH (ovarian reserve), HOMA-IR (calculated insulin resistance index), comprehensive thyroid (Free T3, Free T4) and additional metabolic markers — taking the total to 14–18+ parameters. The full PCOD Profile is comparable to Advanced in scope; the choice often comes down to specific clinical context and physician preference.

3. What does AMH testing reveal about PCOD and ovarian reserve? AMH (Anti-Mullerian Hormone) measures the number of follicles remaining in the ovaries, which is the most reliable indicator of ovarian reserve and fertility potential. In Indian women with PCOD, AMH levels are typically 2 to 4 times higher than normal because of the multiple immature follicles characteristic of polycystic ovaries. AMH is critical for fertility planning, IVF protocol design, predicting response to ovulation induction, and ruling out premature ovarian insufficiency. It is the single biggest reason women choose the Advanced panel over Basic.

4. Why is Jaanch PCOD Advanced recommended before IVF or fertility treatment? Fertility specialists and IVF clinics in India typically require a comprehensive baseline before initiating treatment — including AMH, FSH, LH, prolactin, testosterone, thyroid, insulin resistance and Vitamin D. The Jaanch PCOD Advanced delivers all of these in one sample, eliminating the need for multiple separate test bookings and giving the fertility specialist a complete starting picture. This baseline directly influences medication choice, ovulation induction protocols, IVF stimulation strategy and the prediction of treatment success rates.

5. What additional thyroid and metabolic markers does the Advanced panel include? While the Mini panel includes only TSH and the Basic adds fasting insulin, the Jaanch PCOD Advanced typically expands thyroid evaluation to Free T3 and Free T4 — important because subclinical thyroid disorder is extremely common in PCOD patients and can directly worsen menstrual irregularity and infertility. The metabolic side typically expands to fasting insulin, fasting glucose, HbA1c, HOMA-IR calculation and Vitamin D — giving a complete metabolic risk picture rather than just isolated values.

6. How does HOMA-IR help in PCOD management? HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a calculated value derived from fasting insulin and fasting glucose, expressing insulin resistance as a single number. A HOMA-IR above 2.5 is generally considered indicative of insulin resistance. This single index helps your gynaecologist decide whether to add insulin-sensitising medication like metformin, predict the likelihood of progressing to Type 2 diabetes, and tailor lifestyle interventions to the actual severity of insulin resistance rather than rough estimation.

7. Is Thyrocare Jaanch PCOD Advanced suitable for severe PCOD or PCOS cases? Yes, the Advanced panel is the most appropriate Jaanch tier for severe or complicated PCOD presentations — multiple skipped periods over 3 to 6 months, significant weight gain unresponsive to lifestyle changes, marked acne and hirsutism, persistent acanthosis nigricans, recurrent miscarriage, or PCOD already linked with diabetes, hypertension or dyslipidemia. The breadth of parameters helps the treating doctor identify which biological axis is driving severity, allowing a more targeted and aggressive treatment plan than entry-level panels permit.

8. Should women undergoing infertility treatment take this Advanced panel? Yes, Indian women dealing with infertility — whether from PCOD or being investigated for unexplained infertility — benefit substantially from the Jaanch PCOD Advanced. Many infertility specialists request exactly this combination of AMH, hormonal, metabolic and thyroid markers before starting treatment. The panel also helps differentiate PCOD-related infertility from other causes like thyroid dysfunction, premature ovarian insufficiency, hyperprolactinaemia or insulin-driven anovulation, allowing the correct treatment to begin without unnecessary delays.

9. Can Thyrocare Jaanch PCOD Advanced help monitor long-term PCOD complications? Yes. PCOD increases lifetime risk of Type 2 diabetes, cardiovascular disease, endometrial cancer, fatty liver and metabolic syndrome — risks that develop over 10 to 20 years if PCOD goes uncontrolled. The Advanced panel includes the markers that detect early progression toward these complications, particularly HbA1c (long-term sugar control), HOMA-IR (insulin resistance trajectory), lipid markers and Vitamin D status. Annual repeat testing through the Advanced panel is a practical way for women with established PCOD to track long-term risk in measurable terms.

10. What does the Advanced report tell about cardiac and diabetes risk in PCOD? Indian women with PCOD have a notably higher long-term risk of developing diabetes and early coronary artery disease compared to women without PCOD. The Thyrocare Jaanch PCOD Advanced panel includes the specific markers that quantify this risk — HbA1c indicates whether pre-diabetes is developing, HOMA-IR shows the insulin-resistance burden, lipid markers reveal cardiac risk, and Vitamin D status affects both metabolic and cardiovascular health. A physician reviewing this combined report can give a much more accurate long-term risk assessment than any single test alone.